Combined Ratio Analysis
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended September 30, |
|
|
|
Nine Months Ended September 30, |
|
|
2026 |
|
|
2025 |
|
|
|
2026 |
|
|
2025 |
|
|
|
|
|
|
|
Underwriting ratios: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Loss ratio |
|
|
68.4 |
% |
|
|
93.7 |
% |
|
|
|
50.9 |
% |
|
|
83.2 |
% |
|
Expense ratio |
|
|
44.8 |
% |
|
|
47.5 |
% |
|
|
|
46.2 |
% |
|
|
50.5 |
% |
|
Combined ratio |
|
|
113.2 |
% |
|
|
141.2 |
% |
|
|
|
97.1 |
% |
|
|
133.7 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Contribution to combined ratio from net (favorable) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
adverse prior year development |
|
|
12.7 |
% |
|
|
41.9 |
% |
|
|
|
-5.7 |
% |
|
|
13.3 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Accident year combined ratio |
|
|
100.5 |
% |
|
|
99.3 |
% |
|
|
|
102.8 |
% |
|
|
120.4 |
% |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
The Company's underwriting combined ratio was 113.2% for the third quarter of 2026, compared to 141.2% for the same period in 2025, largely impacted by select reserve strengthening in the quarter.
For the nine months ended September 30, 2026, the Company's overall underwriting combined ratio improved significantly to 97.1%, compared to 133.7% in the prior-year period. This reflects continued progress in the Company's ongoing underwriting operations, partially offset by reserve strengthening associated with its discontinued Commercial Lines portfolio.
The year-to-date improvement reflects the continued benefit of the Company's refined underwriting strategy and more focused Personal Lines portfolio.
Net Investment Income
Net investment income was $1.1 million for the quarter ending September 30, 2026, compared to
$1.3 million in the prior year period.
Change in Fair Value of Equity Securities
During the quarter, the Company reported no change in the fair value of its equity securities, compared to a gain of $13,000 in the prior year period.
Net Income (Loss) allocable to common shareholders
The Company reported a net loss allocable to common shareholders of $1.6 million, or $0.43 per share, for the third quarter of 2026.
Adjusted Operating Income (Loss)
The Company reported an adjusted operating loss of $1.6 million, or $0.42 per share, for the third quarter of 2026, compared to an adjusted operating loss of $2.7 million, or $1.55 per share, for the same period in 2025. For the nine months ended September 30, 2026, the Company reported an